RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Normalized Earnings Analysis of CRH Medical
Normal-course issuer bid (NCIB) does sound wonderful. But isn't investing their $28M FCF (free cash flow) into purchasing anesthesia companies better? Anyone want to venture what a reverse split might do? That would be a quick fix for a price that is too low for most institutions. I prefer they use their money to grow. They are lucky to have a great place to invest their FCF.